期刊文献+

慢性丙型肝炎患者血清HCVRNA水平与AST/ALT比例的关系 被引量:3

Relationship between hepatitis C virus RNA and the ratio of AST/ALT in the patients with chronic hepatitis C
下载PDF
导出
摘要 目的分析抗-HCV阳性患者血清水平HCVRNA与AST/ALT活性的关系;评价AST/ALT比值,HCVRNA水平在判断丙肝患者预后方面的价值。方法采用ELISA法检测抗-HCV,阳性标本分别用荧光PCR试剂盒测定HCVRNA;全自动生化分析仪检测AST/ALT。结果 78份抗-HCV阳性标本经PCR检测后有31份标本含有HCVRNA,HCVRNA拷贝量与AST/ALT比例呈正相关。结论动态监测AST/ALT比例和HCVRNA的水平,可用于丙型肝炎的预后估计。 Objective To investigate the relationship between serum hepatitis C virus RNA and the ratio of aspartate aminotransferase to alanine aminotransferase(AST/ALT ratio) in anti-HCV positive samples of patients,and assess the prognostic validity of the ratio of AST/ALT,HCV-RNA in patients with chronic liver disease.Methods Hepatitis C virus fluorescence PCR diagnostic kit was carried out on the anti-HCV positive samples;the ratio of serum AST/ALT was measured by biochemical instrument.Results Of 78 cases,31 were positive for HCV RNA,the copies of HCV-RNA has correlation with the ratio of AST/ALT.Conclusion The ratio of AST/ALT and the copies of HCV-RNA can be dynamic measured to estimate the prognosis of HCV.
出处 《海南医学》 CAS 2011年第8期115-117,共3页 Hainan Medical Journal
关键词 AST/ALT比值 丙型肝炎病毒核酸 AST/ALT ratio Hepatitis C virus RNA
  • 相关文献

参考文献9

  • 1陈灏珠.内科学[M].4版.北京:人民卫生出版社,1999:141.
  • 2穆士杰,张献清,孙文利,李琳琳.献血员血清ALT值与HBV-DNA和HCV-RNA的关系[J].第四军医大学学报,2001,22(10). 被引量:4
  • 3张丽君.AST/ALT比值测定在病毒性肝炎诊治中的临床意义[J].职业与健康,2005,21(9):1404-1404. 被引量:6
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 5Angulo P, Keaeh JC, Batts KP, et al. Independent predictors of liver fibrosis in patientswith nonalcoholic steatohepatitis[J].Hepatology, 1999, 30(6): 1356-1362.
  • 6Orellana NI, Poniachik T J, Smok SG, et al. Factors associated with the severity of liver damage in chronid hepatis C [J]. Rev Med Chil, 2005, 133(11): 1311-1316.
  • 7Adinolfi LE, Utili R, Andreana A, et al. Serum HCV RNA levels correlate with histological liver damdge and concur with steatosis in progression of chronic hepatitis C [J]. Dig Dis Sci, 2001, 46(8): 1677-1683.
  • 8Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels [J]. Hepatology, 1997, 26(6): 1393-1398.
  • 9袁和俊,胡德昌,翟为溶,张清波,徐永华,周康,刘厚钰.丙型肝炎患者干扰素治疗前后肝内丙型肝炎病毒抗原表达状况[J].中华内科杂志,1997,36(12):830-831. 被引量:3

二级参考文献4

共引文献14029

同被引文献27

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2曾宏,刘集鸿,周华坚.慢性丙型肝炎患者抗病毒治疗前后血清IL-18、IL-10及sFas水平变化与意义[J].现代医药卫生,2006,22(11):1602-1603. 被引量:2
  • 3张瑞,杜绍财.丙型肝炎病毒基因分型的研究进展[J].中华检验医学杂志,2006,29(5):469-471. 被引量:19
  • 4Raza A, Ali Z, Irfan J,et al. Analytical variables influencing the HCV RNA de- termination by TaqMan real-time PCR in routine clinical laboratory practice. Mol Biol Rep, 2012, 39(7):7421-7427.
  • 5Xia QF, Wen YA, Liu P, et al. Use of duplex mutation primers for real-time PCR quan- tification of hepatitis C virus RNA in ser- um[J].Hepat Mon, 2011, 11 (7):519-524.
  • 6Masao Omata,Tatsuo Kanda,Ming-Lung Yu,Osamu Yokosuka,Seng-Gee Lim,Wasim Jafri,Ryosuke Tateishi,Saeed S. Hamid,Wan-Long Chuang,Anuchit Chutaputti,Lai Wei,Jose Sollano,Shiv Kumar Sarin,Jia-Horng Kao,Geoffrey W. McCaughan.APASL consensus statements and management algorithms for hepatitis C virus infection[J].Hepatology International.2012(2)
  • 7Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents(J)Journal of Hepatology . 2010 (6)
  • 8Venessa Pattullo,E. Jenny Heathcote,David K. H. Wong.??Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C(J)Hepatology International . 2010 (4)
  • 9李国平.Fas抗原-配体系统与肝脏疾病研究进展[J].国外医学(临床生物化学与检验学分册),1999,20(1):4-6. 被引量:13
  • 10何海棠,骆抗先,王晋豫,朱幼芙,卢桥生.血清可溶性Fas-和FasL-mRNA检测方法的建立[J].第一军医大学学报,1999,19(1):80-81. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部